Pain in extremity and drugs of ingredients of cromolyn sodium - a phase IV clinical study of FDA data


Summary:

Pain in extremity is found among people who take drugs with ingredients of cromolyn sodium, especially for people who are female, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 6,267 people who have side effects when taking drugs with ingredients of cromolyn sodium from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Crolom, Cromolyn sodium, Cromoptic, Gastrocrom, Intal, Nasalcrom, Opticrom.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Nov, 30, 2022

6,267 people reported to have side effects when taking drugs with ingredients of cromolyn sodium.
Among them, 96 people (1.53%) have Pain in extremity


What is Pain in extremity?

Pain in extremity is found to be associated with 4,295 drugs and 3,958 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of cromolyn sodium cause Pain in extremity?

Time on drugs with ingredients of cromolyn sodium when people have Pain in extremity *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Pain in extremity when taking drugs with ingredients of cromolyn sodium *:

  • female: 56.52 %
  • male: 43.48 %

Age of people who have Pain in extremity when taking drugs with ingredients of cromolyn sodium *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 7.35 %
  • 20-29: 7.35 %
  • 30-39: 13.24 %
  • 40-49: 19.12 %
  • 50-59: 13.24 %
  • 60+: 39.71 %

Conditions people have *:

  1. Osteoporosis (bones weak and more likely to break): 12 people, 12.50%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 11.46%
  3. High Blood Pressure: 10 people, 10.42%
  4. Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 7 people, 7.29%
  5. Stress And Anxiety: 7 people, 7.29%
  6. Muscle Spasms (muscle contraction): 7 people, 7.29%
  7. Actinic Keratosis (skin disease due to sun exposure): 6 people, 6.25%
  8. Pain: 6 people, 6.25%
  9. Constipation: 5 people, 5.21%
  10. Depression: 5 people, 5.21%

Other drugs people take *:

  1. Xolair: 20 people, 20.83%
  2. Zometa: 19 people, 19.79%
  3. Albuterol: 19 people, 19.79%
  4. Singulair: 18 people, 18.75%
  5. Diclofenac Sodium: 18 people, 18.75%
  6. Advair Hfa: 16 people, 16.67%
  7. Ventolin: 16 people, 16.67%
  8. Fluconazole: 15 people, 15.62%
  9. Omeprazole: 15 people, 15.62%
  10. Miralax: 14 people, 14.58%

Other side effects people have besides Pain in extremity *:

  1. Pain: 45 people, 46.88%
  2. Stress And Anxiety: 36 people, 37.50%
  3. Breathing Difficulty: 31 people, 32.29%
  4. Dizziness: 28 people, 29.17%
  5. Muscle Spasms (muscle contraction): 27 people, 28.12%
  6. Nausea (feeling of having an urge to vomit): 26 people, 27.08%
  7. High Blood Pressure: 26 people, 27.08%
  8. Headache (pain in head): 24 people, 25.00%
  9. Fatigue (feeling of tiredness): 24 people, 25.00%
  10. Nasopharyngitis (inflammation of the nasopharynx): 23 people, 23.96%

* Approximation only. Some reports may have incomplete information.


How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drugs with ingredients of cromolyn sodium, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on cromolyn sodium. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: